|
GB9816837D0
(en)
|
1998-08-04 |
1998-09-30 |
Zeneca Ltd |
Amide derivatives
|
|
CA2328962A1
(en)
|
1998-04-17 |
1999-10-28 |
Parker Hughes Institute |
Btk inhibitors and methods for their identification and use
|
|
ID27652A
(id)
|
1998-08-04 |
2001-04-19 |
Astrazeneca Ab |
Turunan amida yang digunakan sebagai inhibitor produksi sitokina
|
|
EP1115707B1
(en)
|
1998-09-25 |
2003-11-12 |
AstraZeneca AB |
Benzamide derivatives and ther use as cytokine inhibitors
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
IL148718A0
(en)
|
1999-09-17 |
2002-09-12 |
Abbott Gmbh & Co Kg |
Pyrazolopyrimidines as therapeutic agents
|
|
ES2367422T3
(es)
|
2001-10-09 |
2011-11-03 |
Amgen Inc. |
Derivados de imidazol como agentes antiinflamatorios.
|
|
EP1546117A2
(en)
*
|
2002-08-14 |
2005-06-29 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
EP1567663A4
(en)
|
2002-12-05 |
2006-04-19 |
Univ Arkansas |
MOLECULAR DETERMINANTS OF MULTIPLE MYELOMA AND ITS USE
|
|
ES2571779T3
(es)
|
2002-12-13 |
2016-05-26 |
Ym Biosciences Australia Pty |
Inhibidores de cinasa a base de nicotinamida
|
|
BRPI0418031A
(pt)
|
2003-12-22 |
2007-04-17 |
Gilead Sciences Inc |
inibidores de quinase fosfonato-substituìdos
|
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
|
CN101084240A
(zh)
|
2004-12-20 |
2007-12-05 |
希格马托制药工业公司 |
MyD88同型二聚体化抑制剂
|
|
CA2589773A1
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Pyridine carboxamide derivatives for use as anticancer agents
|
|
TW200635899A
(en)
|
2004-12-22 |
2006-10-16 |
Astrazeneca Ab |
Chemical compounds
|
|
CN101106990B
(zh)
|
2005-01-26 |
2010-12-08 |
Irm责任有限公司 |
用作蛋白激酶抑制剂的化合物和组合物
|
|
EP1912639A4
(en)
|
2005-08-08 |
2011-10-12 |
Janssen Pharmaceutica Nv |
Thiazolopyrimidine KINASE INHIBITORS
|
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
|
GT200600411A
(es)
|
2005-09-13 |
2007-05-21 |
Novartis Ag |
Combinaciones que comprenden un inhibidor del receptor del factor de crecimiento endotelial vascular
|
|
DK1957461T3
(en)
|
2005-11-14 |
2016-12-19 |
Genentech Inc |
Bisamidhæmmere the hedgehog-signalling
|
|
CA2632929A1
(en)
|
2005-12-22 |
2007-06-28 |
Astrazeneca Ab |
Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
|
|
WO2007076474A1
(en)
*
|
2005-12-23 |
2007-07-05 |
Kalypsys, Inc. |
Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases
|
|
GB0605120D0
(en)
|
2006-03-14 |
2006-04-26 |
Novartis Ag |
Organic Compounds
|
|
US20090312396A1
(en)
*
|
2006-07-10 |
2009-12-17 |
Astrazeneca Ab |
Methods for cancer treatment using tak1 inhibitors
|
|
EA018573B1
(ru)
|
2006-09-22 |
2013-09-30 |
Фармасайкликс, Инк. |
Ингибиторы тирозинкиназы брутона
|
|
EP2486941B1
(en)
|
2006-10-02 |
2017-03-15 |
E. R. Squibb & Sons, L.L.C. |
Human antibodies that bind CXCR4 and uses thereof
|
|
US20120065201A1
(en)
|
2007-03-28 |
2012-03-15 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
|
KR20100016584A
(ko)
|
2007-04-17 |
2010-02-12 |
노파르티스 아게 |
암 치료제로서의 나프탈렌 카르복실산 아미드의 에테르
|
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
TW200906825A
(en)
|
2007-05-30 |
2009-02-16 |
Scripps Research Inst |
Inhibitors of protein kinases
|
|
ES2401557T3
(es)
|
2007-08-02 |
2013-04-22 |
Amgen, Inc |
Moduladores de Pl3 cinasas y métodos de uso
|
|
EP2214486A4
(en)
|
2007-10-19 |
2011-03-09 |
Avila Therapeutics Inc |
HETEROARYL COMPOUNDS AND ITS USES
|
|
US7989465B2
(en)
*
|
2007-10-19 |
2011-08-02 |
Avila Therapeutics, Inc. |
4,6-disubstituted pyrimidines useful as kinase inhibitors
|
|
US8067423B2
(en)
|
2007-10-23 |
2011-11-29 |
Teva Pharmaceutical Industries Ltd. |
Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof
|
|
US8394816B2
(en)
|
2007-12-07 |
2013-03-12 |
Irene Ghobrial |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
|
|
ES2396366T3
(es)
|
2007-12-10 |
2013-02-21 |
Concert Pharmaceuticals Inc. |
Inhibidores heterocíclicos de quinasas
|
|
US8426424B2
(en)
|
2008-05-06 |
2013-04-23 |
Cgi Pharmaceuticals, Inc. |
Certain substituted amides, method of making, and method of use thereof
|
|
SG10201510696RA
(en)
|
2008-06-27 |
2016-01-28 |
Celgene Avilomics Res Inc |
Heteroaryl compounds and uses thereof
|
|
US7824861B2
(en)
|
2008-07-10 |
2010-11-02 |
National Tsing Hua University |
Method for quantitative analysis of transcripts with nucleotide polymorphism at specific site
|
|
PT3081552T
(pt)
|
2008-08-13 |
2021-04-20 |
Mitsui Chemicals Agro Inc |
Agente de controlo de pragas contendo um derivado de amida e utilização do agente de controlo de pragas
|
|
AU2009289378A1
(en)
*
|
2008-09-02 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Novel benzamides, production thereof, and use thereof as medicaments
|
|
US8598174B2
(en)
|
2008-11-12 |
2013-12-03 |
Genetech, Inc. |
Pyridazinones, method of making, and method of use thereof
|
|
JP5416221B2
(ja)
|
2008-12-23 |
2014-02-12 |
ジェネンテック， インコーポレイテッド |
癌患者における診断用途のための方法および組成物
|
|
MX2012002591A
(es)
|
2009-09-03 |
2012-04-02 |
Allergan Inc |
Compuestos como moduladores de tirosina cinasas.
|
|
EP2485589A4
(en)
|
2009-09-04 |
2013-02-06 |
Biogen Idec Inc |
HETEROARYL-BTK INHIBITORS
|
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
|
EP2534151B1
(en)
|
2010-02-08 |
2018-11-14 |
Merck Sharp & Dohme B.V. |
8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
|
|
US20120071497A1
(en)
|
2010-06-03 |
2012-03-22 |
Pharmacyclics, Inc. |
Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinase
|
|
KR101995013B1
(ko)
|
2010-07-13 |
2019-07-02 |
에프. 호프만-라 로슈 아게 |
Irak4 조절제로서 피라졸로[1,5a]피리미딘 및 티에노[3,2b]피리미딘 유도체
|
|
CN103298794A
(zh)
|
2010-11-09 |
2013-09-11 |
塞尔卓姆有限公司 |
作为tyk2抑制剂的吡啶化合物及其氮杂类似物
|
|
US20140080810A1
(en)
|
2010-11-15 |
2014-03-20 |
Exelixis, Inc. |
Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
|
|
BR112013029640A2
(pt)
|
2011-05-23 |
2017-06-13 |
Merck Patent Gmbh |
derivados de piridina e pirazina
|
|
LT2718270T
(lt)
|
2011-06-10 |
2022-08-10 |
Merck Patent Gmbh |
Pirimidino ir piridino junginių, turinčių btk inhibitorinį aktyvumą, kompozicijos ir gamybos būdai
|
|
CA2840687C
(en)
|
2011-07-01 |
2020-04-28 |
Dana-Farber Cancer Institute, Inc. |
Discovery of a somatic mutation in myd88 gene in lymphoplasmacytic lymphoma
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
WO2013050261A1
(en)
|
2011-10-03 |
2013-04-11 |
Syngenta Participations Ag |
Insecticidal 2-methoxybenzamide derivatives
|
|
CN104024257A
(zh)
|
2011-10-04 |
2014-09-03 |
吉利德卡利斯托加有限责任公司 |
Pi3k的新的喹喔啉抑制剂
|
|
BR112014010439A2
(pt)
|
2011-11-03 |
2017-04-18 |
F Hoffmann - La Roche Ag |
compostos, composição farmacêutica, processo de produção, método de tratamento de uma doença ou distúrbio, métodos, kit e uso de uma composição farmacêutica
|
|
AU2012335553B2
(en)
|
2011-11-09 |
2017-09-21 |
Bristol-Myers Squibb Company |
Treatment of hematologic malignancies with an anti-CXCR4 antibody
|
|
CA2856291C
(en)
|
2011-11-17 |
2020-08-11 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
|
CA2857302C
(en)
|
2011-12-15 |
2020-08-25 |
Novartis Ag |
Use of inhibitors of the activity or function of pi3k
|
|
WO2014017659A1
(ja)
|
2012-07-27 |
2014-01-30 |
独立行政法人理化学研究所 |
急性骨髄性白血病の治療又は再発抑制剤
|
|
CN103405429A
(zh)
|
2013-08-22 |
2013-11-27 |
中国药科大学 |
一类vegfr-2抑制剂及其用途
|
|
AU2014318614B2
(en)
|
2013-09-12 |
2021-01-07 |
Dana-Farber Cancer Institute Inc. |
Methods for evaluating and treating Waldenstrom's macroglobulinemia
|
|
WO2015069287A1
(en)
*
|
2013-11-08 |
2015-05-14 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
|
WO2015085075A1
(en)
|
2013-12-06 |
2015-06-11 |
Dana-Farber Cancer Institute, Inc. |
Methods to distinguish waldenström's macroglobulinemia from igm monoclonal gammopathy of undetermined significance
|
|
US9908872B2
(en)
|
2013-12-13 |
2018-03-06 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
JP6879740B2
(ja)
|
2013-12-13 |
2021-06-02 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
リンパ形質細胞性リンパ腫を処置する方法
|
|
WO2016055982A1
(en)
|
2014-10-10 |
2016-04-14 |
Acerta Pharma B.V. |
Quinoline and quinazoline compounds
|
|
JP6788583B2
(ja)
|
2014-10-22 |
2020-11-25 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
増殖性疾患を処置するためのチアゾリル含有化合物
|
|
WO2017172826A1
(en)
|
2016-03-28 |
2017-10-05 |
Presage Biosciences, Inc. |
Pharmaceutical combinations for the treatment of cancer
|
|
JP2019518006A
(ja)
|
2016-04-29 |
2019-06-27 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
Ｍｙｄ８８変異型疾患における治療標的としてのｈｃｋ
|
|
CN106008371A
(zh)
|
2016-06-24 |
2016-10-12 |
谢阳 |
1-芳基脲基环烷基-1-甲酰胺类化合物及其药物组合物和应用
|
|
CN106279120A
(zh)
|
2016-07-15 |
2017-01-04 |
谢阳 |
一种n‑芳基氨基甲酰基脯氨酸类化合物及其药物组合物和应用
|
|
CN107056786B
(zh)
|
2016-10-14 |
2019-05-07 |
苏州明锐医药科技有限公司 |
阿卡替尼的制备方法
|
|
AU2018272986A1
(en)
|
2017-05-26 |
2019-12-12 |
Ichnos Sciences SA |
Novel inhibitors of MAP4K1
|
|
KR20220098732A
(ko)
|
2019-10-08 |
2022-07-12 |
다나-파버 캔서 인스티튜트 인크. |
요법, 특히 myd88 돌연변이된 질환에 사용하기 위한 hck 억제제로서의 피라졸로피리미딘 유도체
|
|
WO2021071919A1
(en)
|
2019-10-08 |
2021-04-15 |
Dana-Farber Cancer Institute, Inc. |
Hck as a therapeutic target in myd88 mutated diseases
|